Identification of β-glucosidase 1 as a biomarker and its high expression in hepatocellular carcinoma is associated with resistance to chemotherapy drugs.


CONTEXT AND OBJECTIVE Long-term prognosis of hepatocellular carcinoma (HCC) patients is challenging, and novel biomarkers are needed to predict patient risk and serve as potential therapeutic target. RESULTS We found β-glucosidase 1 is significantly overexpressed and activated in primary HCC tissue and multiple HCC cell lines. β-Glucosidase 1 expression… (More)
DOI: 10.3109/1354750X.2015.1134662


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics